136 related articles for article (PubMed ID: 15100376)
41. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
[TBL] [Abstract][Full Text] [Related]
42. Level of renal function and serum erythropoietin levels independently predict anaemia post-renal transplantation.
Sinnamon KT; Courtney AE; Maxwell AP; McNamee PT; Savage G; Fogarty DG
Nephrol Dial Transplant; 2007 Jul; 22(7):1969-73. PubMed ID: 17353209
[TBL] [Abstract][Full Text] [Related]
43. National survey of anemia prevalence after kidney transplantation in Argentina.
Petrone H; Arriola M; Re L; Taylor F; Bruzzone M; Chiurchu C; Schiavelli R;
Transplant Proc; 2010; 42(1):288-90. PubMed ID: 20172333
[TBL] [Abstract][Full Text] [Related]
44. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
45. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
[TBL] [Abstract][Full Text] [Related]
46. Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
Kuypers DR; Malaise J; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii33-9, ii62. PubMed ID: 15814548
[TBL] [Abstract][Full Text] [Related]
47. Mycophenolate mofetil and C-reactive protein in renal transplant recipients.
Wong BM; Huang M; Zaltzman JS; Prasad GV
Transplantation; 2007 Jan; 83(1):48-53. PubMed ID: 17220790
[TBL] [Abstract][Full Text] [Related]
48. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
Ferreira A; Felipe C; Cristelli M; Viana L; Basso G; Stopa S; Mansur J; Ivani M; Bessa A; Ruppel P; Aguiar W; Campos E; Gerbase-DeLima M; Proença H; Tedesco-Silva H; Medina-Pestana J
Am J Nephrol; 2017; 45(6):497-508. PubMed ID: 28511172
[TBL] [Abstract][Full Text] [Related]
49. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
Gentil MA; Pérez-Valdivia MA; González-Roncero FM; López-Mendoza M; Cabello V; Bernal G; Suñer M; Pereira P
Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
[TBL] [Abstract][Full Text] [Related]
50. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
[TBL] [Abstract][Full Text] [Related]
51. Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study.
Hernández D; Muriel A; Abraira V; Pérez G; Porrini E; Marrero D; Zamora J; González-Posada JM; Delgado P; Rufino M; Torres A
Nephrol Dial Transplant; 2012 Jan; 27(1):417-22. PubMed ID: 21622985
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients.
Gossmann J; Thürmann P; Bachmann T; Weller S; Kachel HG; Schoeppe W; Scheuermann EH
Kidney Int; 1996 Sep; 50(3):973-8. PubMed ID: 8872973
[TBL] [Abstract][Full Text] [Related]
53. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
[TBL] [Abstract][Full Text] [Related]
54. [Incidence and management of anemia in renal transplantation: an observational-French study].
Choukroun G; Deray G; Glotz D; Lebranchu Y; Dussol B; Bourbigot B; Lefrançois N; Cassuto-Viguier E; Toupance O; Hacen C; Lang P; Mazouz H; Martinez F
Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417
[TBL] [Abstract][Full Text] [Related]
55. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
Flechner SM; Kobashigawa J; Klintmalm G
Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
[TBL] [Abstract][Full Text] [Related]
56. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results.
Chamienia A; Dębska-Ślizień A; Król E; Biedunkiewicz B; Rutkowski B
Transplant Proc; 2014 Oct; 46(8):2714-8. PubMed ID: 25380901
[TBL] [Abstract][Full Text] [Related]
57. Mammalian Target of Rapamycin Inhibitor Monotherapy: Efficacy in Renal Transplantation.
Franco A; Más-Serrano P; Perez Contreras J; Jiménez L; Rodriguez D; Olivares J
Transplant Proc; 2015 Oct; 47(8):2364-7. PubMed ID: 26518928
[TBL] [Abstract][Full Text] [Related]
58. Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis.
Al-Uzri A; Yorgin PD; Kling PJ
Pediatr Transplant; 2003 Aug; 7(4):253-64. PubMed ID: 12890002
[TBL] [Abstract][Full Text] [Related]
59. Posttransplantation anemia in kidney transplant recipients: A retrospective cohort study.
Gafter-Gvili A; Ayalon-Dangur I; Cooper L; Shochat T; Rahamimov R; Gafter U; Mor E; Grossman A
Medicine (Baltimore); 2017 Aug; 96(32):e7735. PubMed ID: 28796058
[TBL] [Abstract][Full Text] [Related]
60. Risk factors of post renal transplant anaemia among Sudanese patients, a study in three renal transplant centres.
Banaga AS; Yousif ME; Elmusharaf K
BMC Nephrol; 2011 Aug; 12():37. PubMed ID: 21827693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
